What Techsol Life Sciences does

Techsol Life Sciences is a privately held, for-profit scientific services and technology firm founded in 2010 and headquartered in Princeton, New Jersey. The company delivers technology and scientific business solutions to pharmaceutical clients, with an organizational structure that includes a dedicated CRO (Contract Research Organization) services practice led at the co-founder level, indicating outsourcing-style engagements such as clinical or pre-clinical research support, scientific operations, and related technical services for pharma sponsors. Its 251-500 employee headcount, co-located with the U.S. pharma R&D corridor in New Jersey, points to a mid-sized services firm rather than a software product company, and the breadth of co-founder titles (CRO Services, Operations, Senior Director) suggests multiple parallel service lines operating under a single brand.

The leadership remains founder-led after more than a decade, with Satya S S Sagi serving as Founder and CEO alongside co-founders Jonathan Sunkyu Kim, Vinoth Kumar Thirupathy, Laxman J Kumar, and Sriram Varma, who collectively hold operating responsibility for CRO services, operations, and senior direction. This stability is operationally relevant for a services business where client relationships and scientific credibility depend on continuity. The company operates as a private entity with no public ticker and no disclosed funding rounds in the source material, implying either bootstrapped growth or privately arranged capital.

The business model is consistent with a professional services / CRO construct: revenue is generated through fee-for-service engagements with pharma clients, sized at a headcount band that maps to roughly $40M-$125M in implied annual revenue. No pricing model, customer roster, geographic footprint, product portfolio, or technology stack information was available in the source material, so the depth of the technology and product layer behind the "innovative technology" positioning cannot be characterized from the supplied data.

Name

Techsol Life Sciences

Website

https://techsollifesciences.com

Company type

Private

Founded year

2010

Headcount range

251–500 employees

Short description

Techsol Life Sciences is a private, founder-led scientific services and technology firm based in Princeton, NJ, founded in 2010, that delivers technology-enabled CRO services and scientific business solutions to pharmaceutical companies.

Ownership category

akta.pro rank

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

Techsol Life Sciences provides innovative technology and scientific business solutions for pharmaceutical companies. The firm was founded in 2010 and is headquartered in Princeton, United States, operating with 251-500 employees to support drug development and research operations for pharma clients.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO specializing in clinical research across multiple therapeutic areas for small and mid-sized biopharma. It is a closely comparable peer to Techsol in scale, service mix, and target sponsor segment.
• Medpace: Medpace is a mid-to-large full-service CRO focused on small and mid-sized biopharma sponsors, with strong operational execution in clinical operations. It is a directly comparable peer to Techsol as a CRO serving pharma, though with significantly greater scale and public-company resources.

Emerging players

• Pharmaron: Pharmaron is a global CRO/CDMO providing integrated drug discovery, preclinical, CMC, and clinical services to pharma and biotech. It is comparable to Techsol in offering a technology-and-scientific-services hybrid, though Pharmaron has significantly larger scale and broader global footprint.

Broad incumbents

• Syneos Health: Syneos Health is a global biopharmaceutical services organization offering clinical and commercial solutions. It overlaps with Techsol's clinical/pharma services orientation and competes for sponsor outsourcing budgets at the mid-market tier.
• ICON plc: ICON is a top-3 global CRO offering full-service clinical, bioanalytical, and lab services to pharma and biotech sponsors. It competes with Techsol for outsourced clinical and scientific services work, but at significantly larger scale and broader geographic footprint.
• Parexel International: Parexel is a global CRO with deep expertise in clinical operations, regulatory, and biopharma consulting. It is a comparable peer competing for similar pharma-sponsored work, but operating at substantially larger scale than Techsol.
• Charles River Laboratories: Charles River provides CRO, CDMO, and research models services across early-stage drug discovery, preclinical, and clinical work. It overlaps with Techsol's scientific/clinical services offering and competes for the same biotech and pharma sponsor budgets.
• IQVIA: IQVIA is the largest global CRO and life sciences technology/services provider, combining clinical research, real-world evidence, and proprietary analytics platforms. It is comparable to Techsol as a competitor for pharma-sponsored work, though IQVIA operates at vastly greater scale and across the full service spectrum.
• Labcorp Drug Development (Fortrea): Fortrea (spun out from Labcorp) is a global CRO providing clinical development, laboratory, and commercialization services. It is comparable to Techsol as a CRO competitor, though with substantially broader service portfolio and global reach.
• WuXi AppTec: WuXi AppTec is a leading global CRO/CDMO offering discovery, development, and laboratory services across the full drug lifecycle. It overlaps with Techsol's scientific business solutions positioning and competes for the same outsourcing budgets, though at much greater scale and geographic reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/Techsol_LS
• Facebookfacebook.com/TechsolLifeSciences
• LinkedInlinkedin.com/company/techsol-life-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Techsol Life Sciences